In a major milestone the obesity rate dropped by roughly 2% between 2020 and 2023 according to the national health and ...

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

Read the latest Collecties Wegovy Ozempic news for entrepreneurs and small businesses from Inc. See related articles, photos, ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...